Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?

被引：0
|
作者：
Rossella E Nappi
Gabriele S Merki-Feld
Erica Terreno
Alice Pellegrinelli
Michele Viana
机构：
[1] IRCCS S. Matteo Foundation,Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause
[2] University of Pavia,Department of Clinical, Surgical, Diagnostic and Paediatric Sciences
[3] University Hospital Zürich,Clinic for Reproductive Endocrinology
[4] Headache Science Center - National Neurological Institute C. Mondino,Research Center for Reproductive Medicine, Unit of Obstetrics and Gynecology
[5] IRCCS Policlinico ‘San Matteo’,undefined
来源：
The Journal of Headache and Pain | 2013年 / 14卷
关键词：
Migraine with aura (MA); Migraine without aura (MO); Combined hormonal contraceptives (CHCs); Combined oral contraceptives (COCs); Progestogen-only contraception; Desogestrel-only pill; Venous thromboembolism (VTE); Stroke;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A significant number of women with migraine has to face the choice of reliable hormonal contraception during their fertile life. Combined hormonal contraceptives (CHCs) may be used in the majority of women with headache and migraine. However, they carry a small, but significant vascular risk, especially in migraine with aura (MA) and, eventually in migraine without aura (MO) with additional risk factors for stroke (smoking, hypertension, diabetes, hyperlipidemia and thrombophilia, age over 35 years). Guidelines recommend progestogen-only contraception as an alternative safer option because it does not seem to be associated with an increased risk of venous thromboembolism (VTE) and ischemic stroke.
引用
收藏
相关论文
共 50 条
  • [21] ULTRASOUND DEMONSTRATION OF INCREASED FREQUENCY OF FUNCTIONAL OVARIAN CYSTS IN WOMEN USING PROGESTOGEN-ONLY ORAL CONTRACEPTION
    TAYOB, Y
    ADAMS, J
    JACOBS, HS
    GUILLEBAUD, J
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1985, 92 (10): : 1003 - 1009
  • [22] Hormonal contraception and migraine
    MacGregor, EA
    [J]. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2001, 27 (01): : 49 - 52
  • [23] Effect of progestogen-only contraception on premenopausal fracture risk: a case-control study
    Kyvernitakis, I
    Kostev, K.
    Thomasius, F.
    Stumpf, U.
    Hadji, P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (09) : 1801 - 1806
  • [24] ORAL PROGESTOGEN-ONLY CONTRACEPTION MAY PROTECT AGAINST LOSS OF BONE MASS IN BREAST-FEEDING WOMEN
    CAIRD, LE
    REIDTHOMAS, V
    HANNAN, WJ
    GOW, S
    GLASIER, AF
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 41 (06) : 739 - 745
  • [25] Effect of progestogen-only contraception on premenopausal fracture risk: a case-control study
    I. Kyvernitakis
    K. Kostev
    F. Thomasius
    U. Stumpf
    P. Hadji
    [J]. Osteoporosis International, 2020, 31 : 1801 - 1806
  • [26] SULPIRIDE AND THE POTENTIATION OF PROGESTOGEN ONLY CONTRACEPTION
    TAYOB, Y
    GUILLEBAUD, J
    [J]. BRITISH MEDICAL JOURNAL, 1985, 291 (6503): : 1206 - 1206
  • [27] SULPIRIDE AND THE POTENTIATION OF PROGESTOGEN ONLY CONTRACEPTION
    WINTON, F
    [J]. BRITISH MEDICAL JOURNAL, 1985, 291 (6502): : 1127 - 1127
  • [28] SULPIRIDE AND THE POTENTIATION OF PROGESTOGEN ONLY CONTRACEPTION
    SCHIFF, AA
    [J]. BRITISH MEDICAL JOURNAL, 1985, 291 (6506): : 1424 - 1424
  • [29] SULPIRIDE AND THE POTENTIATION OF PROGESTOGEN ONLY CONTRACEPTION
    PAYNE, MR
    HOWIE, PW
    MCNEILLY, AS
    COOPER, W
    MARNIE, M
    KIDD, L
    [J]. BRITISH MEDICAL JOURNAL, 1985, 291 (6495): : 559 - 561
  • [30] CHOICE OF HORMONAL CONTRACEPTION
    KELLER, PJ
    [J]. SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1979, 68 (13): : 408 - 411
12345